Status:
NOT_YET_RECRUITING
Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Herpes Zoster
Neuralgia, Postherpetic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, it was aimed to compare the effect of subcutaneous lidocaine injection, which is routinely applied in pain clinic,in patients who present with pain complaints due to acute herpes zoster...
Detailed Description
Herpes zoster (HZ; shingles) is a disease associated with inflammation of peripheral nerves, which can progress with acute and chronic pain, and is considered a significant cause of postherpetic neura...
Eligibility Criteria
Inclusion
- patients over the age of 18
- with acute HZ pain (rash duration \< 30 days
- pain due to PHN (rash duration \> 3 months),
Exclusion
- patients on anticoagulants or have coagulation disorders, patients with psychomotor disorders patients with uncontrolled diabetes patients with bacterial infection or infectious discharge in the affected dermatomal region patients allergic to lidocaine patients with lesions in the facial or genital regions pregnant or breastfeeding patients
Key Trial Info
Start Date :
March 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 6 2025
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06882525
Start Date
March 7 2025
End Date
December 6 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Üniversiteler Mahallesi 1604. Cadde No: 9 Çankaya/ANKARA
Ankara, Cankaya, Turkey (Türkiye), 06800